Taxonomic, genetic, chemical and estrogenic characteristics of Epimedium species.
暂无分享,去创建一个
P Shen | B L Guo | Y Gong | Deborah Y Q Hong | Y Hong | E L Yong | Y. Hong | P. Shen | E. Yong | Y. Gong | B. Guo
[1] K. M. Chen,et al. Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. , 2005, Die Pharmazie.
[2] Willem G Schoonen,et al. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[3] J. J. Liu,et al. Optimization for quantitative determination of four flavonoids in Epimedium by capillary zone electrophoresis coupled with diode array detection using central composite design. , 2006, Journal of chromatography. A.
[4] Hao Wu,et al. Chemical and pharmacological investigations of Epimedium species: a survey. , 2003, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[5] Francisco Gamarro,et al. Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. , 2005, Cancer research.
[6] S. Milligan,et al. Estrogenic activity of a polyphenolic extract of the leaves of Epimedium brevicornum. , 2005, Fitoterapia.
[7] Choon Nam Ong,et al. Herbal and traditional medicine : molecular aspects of health , 2004 .
[8] D. McDonnell. Mining the complexities of the estrogen signaling pathways for novel therapeutics. , 2003, Endocrinology.
[9] R. Santen,et al. Recombinant cell ultrasensitive bioassay for measurement of estrogens in postmenopausal women. , 2005, The Journal of clinical endocrinology and metabolism.
[10] E. Lobenhofer,et al. Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. F. Stevens,et al. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. , 2000, The Journal of clinical endocrinology and metabolism.
[12] Y. Shoyama,et al. Genetic characterization of Epimedium species using random amplified polymorphic DNA (RAPD) and PCR-restriction fragment length polymorphism (RFLP) diagnosis. , 1996, Biological and Pharmaceutical Bulletin.
[13] B. Efron,et al. Bootstrap confidence levels for phylogenetic trees. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Chiu,et al. Effect of Epimedium brevicornum Maxim extract on elicitation of penile erection in the rat. , 2006, Urology.
[15] P. Shaw,et al. A phylogenetic analysis of Epimedium (Berberidaceae) based on nuclear ribosomal DNA sequences. , 2005, Molecular phylogenetics and evolution.
[16] M. Butler,et al. New estrogenic prenylflavone from Epimedium brevicornum inhibits the growth of breast cancer cells. , 2005, Planta medica.
[17] P. Xiao,et al. [Comment on main species of herba epimedii]. , 2003, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[18] K. Fu,et al. Studies on contributing factors in temporomandibular disorders. , 1999, The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association.
[19] Margaret Warner,et al. Reflections on the Discovery and Significance of Estrogen Receptor (cid:1) , 2005 .
[20] H. Sirén,et al. Characterization of flavonoids in extracts from four species of Epimedium by micellar electrokinetic capillary chromatography with diode-array detection. , 1997, Journal of chromatographic science.
[21] H. Cidade,et al. Effects of natural prenylated flavones in the phenotypical ER (+) MCF-7 and ER (-) MDA-MB-231 human breast cancer cells. , 2006, Toxicology letters.
[22] P. Leung,et al. Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. , 2006, Bone.
[23] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[24] Y. Li,et al. Osteoblastic proliferative activity of Epimedium brevicornum Maxim. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[25] P. Shen,et al. Dimeric progestins from rhizomes of Ligusticum chuanxiong. , 2006, Phytochemistry.